摘要
目的观察缩宫素配伍欣母沛防治产后出血的临床效果。方法研究在我院住院分娩的97例产妇,按照完全随机设计原则分为研究组50位和对照组47位,对照组应用宫缩素和米索前列醇,而研究组应用缩宫素和欣母沛防治产妇产后出血,比较两组患者的产后出血量。结果研究组的产后2 h出血量为(202.34±29.57)mL,产后24 h的出血量为(246.51±22.52)mL;对照组相产后2 h出血量为(274.97±26.18)mL,产后24 h出血量为(307.83±12.62)ml;两组出血量的t检验有统计学意义(P<0.05)。结论缩宫素配伍欣母沛防治产妇产后出血有比较好的临床效果,既安全又可靠,可以临床推广。
Objective Observe the clinical effect of the prevention and control of postpartum hemorrhage by using hemabate and oxytocin. Methods Study 97 cases of puerperae in our hospital by dividing them into study group of 50 cases used hemabate and oxytocin and control group of 47 cases used oxytocin and misoprostol to prevent puerperae from bleeding, according to the princi- ple of completely randomized design, then compare the two groups＇ quantity of bleeding. Results 2 hours post-partum quality of bleeding of Study Group is （202.34±29.57） mL; 24 hours post-partum quality of bleeding of Study Group is （246.51±22.52） mL; 2 hours post-partum quality of bleeding of control Group is （274.97±26.18） mL; 24 hours post-partum quality of bleeding of Study Group is （307.83±12.62） mL; the t-test of two groups＇quantity of bleeding was statistically significant （P 〈 0.05）. Conclusion Hemabate and oxytocin used in the prevention of postpartum hemorrhage have better clinical results, which is safe and reliable and can be clinical.
出处
《中外医疗》
2012年第14期30-31,共2页
China & Foreign Medical Treatment
关键词
宫缩素
欣母沛
产后出血
防治
Oxytocin
Hemabate
Postpartum hemorrhage
Prophylaxis and treatment
